Schott Pharma Ag & CO Kgaa (1SXP.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 986,210 | 957,091 | 898,602 | 821,144 | 648,668 |
| Cost of Goods | 653,746 | 634,481 | 582,113 | 524,717 | 422,499 |
| Gross Profit | 332,464 | 322,610 | 316,489 | 296,427 | 226,169 |
| Operating Expenses | 145,493 | 132,654 | 145,566 | 127,742 | 110,920 |
| Operating Income | 186,971 | 189,956 | 170,923 | 168,685 | 115,249 |
| Interest Expense | 20,011 | 13,487 | 7,254 | 2,686 | 1,674 |
| Other Income | 20,796 | 7,502 | 22,133 | -7,711 | 9,709 |
| Pre-tax Income | 187,756 | 183,971 | 185,802 | 158,288 | 123,284 |
| Income Tax | 40,774 | 33,626 | 33,868 | 32,441 | 22,117 |
| Net Income Continuous | 146,982 | 150,345 | 151,934 | 125,847 | 101,167 |
| Minority Interests | -528 | -660 | -92 | -469 | -414 |
| Net Income | $146,454 | $149,685 | $151,842 | $125,379 | $100,753 |
| EPS Basic Total Ops | 0.97 | 0.99 | 1.01 | 0.83 | 0.67 |
| EPS Basic Continuous Ops | 0.97 | 0.99 | 1.01 | N/A | N/A |
| EPS Diluted Total Ops | 0.97 | 0.99 | 1.01 | 0.83 | 0.67 |
| EPS Diluted Continuous Ops | 0.97 | 0.99 | 1.01 | N/A | N/A |
| EBITDA(a) | $287,207 | $262,436 | $244,904 | $216,331 | $161,402 |